Oclaman, Romeo C.

HRN: 28-99-19  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/12/2026
05/18/2026
IV
4.5g LD Then 2.25g
Q6
Septic Shock Probably Secondary To CAP-MR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  PneumoniaUnspecified Sepsis    Compliance to guidelines: Compliant To Guidelines